Team around BONAC Corporation develops RNAi-agents which cure acute lung injury and pulmonary fibrosis in a mouse model

Title of article is “Efficacy of a Novel Class of RNA Interference Therapeutic Agents”

Hamasaki T et al. (2012) PLoS ONE 7(8): e42655

Team around BONAC Corporation develops RNAi-agents which cure acute lung injury and pulmonary fibrosis in a mouse model
Scroll to top